James D. Marks
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Monoclonal and Polyclonal Antibodies Research
- Neurology top 0.2%
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
Papers in
-
- Glycosylation and Glycoproteins Research 61
- Protein purification and stability 24
- Advanced Biosensing Techniques and Applications 21
-
- Monoclonal and Polyclonal Antibodies Research 113
- Co-authors
- Greg Winter (10 shared papers)Dmitri B. Kirpotin (27 shared papers)Gregory P. Adams (17 shared papers)Ulrik B. Nielsen (15 shared papers)Jianlong Lou (52 shared papers)Keelung Hong (13 shared papers)Christopher C. Benz (12 shared papers)John W. Park (11 shared papers)
- Journals
- Journal of Molecular Biology (16 papers)Cancer Research (11 papers)Toxins (11 papers)PLoS ONE (8 papers)Protein Engineering Design and Selection (6 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
James D. Marks
219 papers receiving 15.4k citations
James D. Marks's Hit Papers
Peers
Comparison fields: 5 of 140
- Radiology, Nuclear Medicine and Imaging 7.6k
- Neurology 2.3k
- Biomaterials 1.9k
- Molecular Biology 8.2k
- Immunology 2.4k
Countries citing papers authored by James D. Marks
This map shows the geographic impact of James D. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Marks more than expected).
Fields of papers citing papers by James D. Marks
This network shows the impact of papers produced by James D. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Marks. The network helps show where James D. Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside James D. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models Hit paper breakdown → | 2006 | 960 |
| 2 | Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Hit paper breakdown → | 2002 | 568 |
| 3 | The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loops Hit paper breakdown → | 1992 | 559 |
| 4 | High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Hit paper breakdown → | 2001 | 542 |
| 5 | 1993 | 413 | |
| 6 | 1998 | 374 | |
| 7 | Structural repertoire of the human VH segments Hit paper breakdown → | 1992 | 342 |
| 8 | By–Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling Hit paper breakdown → | 1992 | 339 |
| 9 | 1996 | 330 | |
| 10 | 2006 | 326 | |
| 11 | 2011 | 288 | |
| 12 | 2002 | 287 | |
| 13 | 2001 | 274 | |
| 14 | 2004 | 257 | |
| 15 | 2005 | 248 | |
| 16 | 2004 | 245 | |
| 17 | 1990 | 229 | |
| 18 | 1998 | 216 | |
| 19 | 1991 | 193 | |
| 20 | Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. | 1998 | 193 |
About James D. Marks
James D. Marks is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Neurology, Cellular and Molecular Neuroscience and Oncology, having authored 222 papers that have together received 16.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (113 papers), Glycosylation and Glycoproteins Research (61 papers), Botulinum Toxin and Related Neurological Disorders (59 papers), Neurological disorders and treatments (39 papers), Hereditary Neurological Disorders (29 papers), Protein purification and stability (24 papers), Advanced Biosensing Techniques and Applications (21 papers) and HER2/EGFR in Cancer Research (19 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (7.6k citations), Neurology (2.3k citations), Biomaterials (1.9k citations), Molecular Biology (8.2k citations) and Immunology (2.4k citations). James D. Marks has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Greg Winter, Dmitri B. Kirpotin, Gregory P. Adams, Ulrik B. Nielsen, Jianlong Lou, Keelung Hong, Christopher C. Benz, John W. Park, Daryl C. Drummond and Robert Schier. Their work appears in journals such as Journal of Molecular Biology, Cancer Research, Toxins, PLoS ONE and Protein Engineering Design and Selection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.